Opportunities in biopharmaceutical production: Biologics and new technologies

Last year at the BioProcess International Event, we had the opportunity to sit down with a few of the speakers and discuss what they see is impacting their jobs, some of the opportunities in the industry and emerging markets he works in.

In this video,  Günter Jagschies, Ph.D., GE Healthcare addresses:

• -Where he sees the industry headed in the slow moving, regulated biopharmaceutical industry
• -How biosimilars will change the field over the next few years
• -How the cost of drug development needs to change
• -Emerging technologies

Watch the full video here:


GE Healthcare will return to BioProcess International this year as a Gold Sponsor and will be presenting the technology workshop Guidelines for the Selection of Chromatography Media (Resins) and Steps to Meet Specific Purification Challenges.  To find out more about this workshop and the rest of the program, download the agenda.  If you'd like to join us October 20-23, 2014 in Boston, MA for the BioProcess International Conference and Exhibition, as a reader of this blog, when you register to join us and mention code BPI14BLOG, you can save 20% off the standard rate!  Would you like to get invovled in the event?  Feel free to reach out to Jennifer Pereira.

Share this article with your social network, just click below to share now!

Share |